Evidence map›Paper›PMID 39345172›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection.

Hector M Nieves-Rosado, Hridesh Banerjee, Angela Gocher-Demske, Priyanka Manandhar, Isha Mehta, Ogechukwu Ezenwa, Bingxian Xie, Ben Murter, Jishnu Das, Dario A A Vignali and 2 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hector M Nieves-RosadoDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-8084-0728
Hridesh BanerjeeDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-4536-4102
Angela Gocher-DemskeDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.
Priyanka ManandharDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-2868-5286
Isha MehtaDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-6009-0787
Ogechukwu EzenwaDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0009-0007-1184-542X
Bingxian XieDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-9816-2670
Ben MurterDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-3035-3782
Jishnu DasDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-5747-064X
Dario A A VignaliDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-2771-5992
Greg M DelgoffeDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-2957-8135
Lawrence P KaneDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-5198-516X

Funding

TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
Training in Cellular & Molecular Mechanisms of Tumor RejectionT32CA082084 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert J Binder, Dario AA Vignali · 1999 to 2026
$9.2M
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytesR01CA206517 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert L. Ferris, Lawrence P. Kane · 2016 to 2026
$4.6M
Dissecting the role of hypoxia in T cell differentiation in cancerR01CA277473 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Greg M. Delgoffe, Yana Najjar · 2023 to 2026
$2.4M
Metabolic control of regulatory T cell functional identityR01AI171483 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELGOFFE, GREG M. · 2022 to 2025
$2.4M
Exploring and exploiting metabolic plasticity in regulatory T cellsDP2AI136598 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELGOFFE, GREG M. · 2017 to 2017
$2.3M
Regulation of T cell activation and exhaustion by Tim-3R01AI138504 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KANE, LAWRENCE P. · 2018 to 2021
$1.7M
Bigfoot Spectral Cell SorterS10OD032265 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KANE, LAWRENCE P. · 2022 to 2022
$755k
Elucidating The Roles of PIK3IP1/TrIP Regulation on Distinct T Cell Subsets in the Context of CancerF31CA261039 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MURTER, BENJAMIN · 2022 to 2024
$117k
HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM008208HHS | NIH | NCI | Center for Cancer Research (CCR) F31CA261039HHS | NIH | NCI | Center for Cancer Research (CCR) R01CA206517HHS | NIH | NCI | Center for Cancer Research (CCR) T32CA082084HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R01AI138504HHS | NIH | NIH Office of the Director (OD) S10OD032265NCI NIH HHS R01 CA206517NCI NIH HHS R01 CA277473NIAID NIH HHS DP2 AI136598NIAID NIH HHS R01 AI138504NIAID NIH HHS R01 AI171483NIH HHS S10 OD032265
6 · The paper itself

Abstract

Expression of T cell Ig and mucin domain-containing protein 3 (Tim-3) is upregulated on regulatory T cells (Tregs) during chronic viral infections. In several murine and human chronic infections, the expression of Tim-3 is associated with poor control of viral burden and impaired antiviral immune responses. However, the role of Tim-3+ Tregs during persistent viral infections has not been fully defined. We employed an inducible Treg-specific Tim-3 loss-of-function (Tim-3 Treg knockout) murine model to dissect the role of Tim-3 on Tregs during chronic lymphocytic choriomeningitis virus infection. Tim-3 Treg knockout mice exhibited a decrease in morbidity, a more potent virus-specific T cell response, and a significant decrease in viral burden. These mice also had a reduction in the frequency of PD-1+Tim-3+ and PD-1+Tox+ gp33-specific exhausted CD8+ T cells. Our findings demonstrate that modulation of a single surface protein on Tregs can lead to a reduction in viral burden, limit T cell exhaustion, and enhance gp33-specific T cell response. These studies may help to identify Tim-3-directed therapies for the management of persistent infections and cancer.

Indexed as

Hepatitis A Virus Cellular Receptor 2Lymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMice, KnockoutT-Lymphocytes, RegulatoryAnimalsCD8-Positive T-LymphocytesChronic DiseaseMiceMice, Inbred C57BLPersistent InfectionProgrammed Cell Death 1 ReceptorT-Cell ExhaustionViral LoadHavcr2 protein, mouseHepatitis A Virus Cellular Receptor 2Pdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID39345172
PMCPMC11671103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.